References
- S Khan, V Mishra, F Arnold. Contraceptive Trends in Developing Countries. 2007; Macro International Inc.: Calverton, Maryland, USADHS Comparative Reports No. 16
- S Singh, JE Darroch, LS Ashford. Adding It Up: The Costs and Benefits of Investing in Family Planning and Maternal and Newborn Health. 2009; Guttmacher Institute and United Nations Population Fund: New York.
- World Health Organization. Hormonal Contraception and HIV: Technical Statement. 2012 February; World Health Organization: GenevaReport No.: WHO/RHR/12.08
- L Lavreys, JM Baeten, HL Martin Jr.. Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. AIDS. 18(4): 2004; 695–697.
- I Kleinschmidt, H Rees, S Delany. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception. 75(6): 2007; 461–467.
- CS Morrison, BA Richardson, F Mmiro. Hormonal contraception and the risk of HIV acquisition. AIDS. 21(1): 2007; 85–95.
- CS Morrison, P-L Chen, C Kwok. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS. 24(11): 2010; 1778–1781.
- JM Baeten, S Benki, V Chohan. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS. 21: 2007; 1771–1777.
- L Myer, L Denny, TC Wright. Prospective study of hormonal contraception and women’s risk of HIV infection in South Africa. International Journal of Epidemiology. 36: 2007; 166–174.
- SE Reid, JY Dai, J Wang. Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. Journal of Acquired Immune Deficiency Syndromes. 53: 2010; 606–613.
- D Watson-Jones, K Baisley, HA Weiss. Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania. AIDS. 23: 2009; 415–422.
- R Heffron, D Donnell, H Rees. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infectious Diseases. 12(1): 2012; 19–26.
- H Wand, G Ramjee. The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS. 26: 2012; 375–380.
- CS Morrison, S Skoler-Karpoff, C Kwok. Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS. 26: 2012; 497–504.
- Chirenje ZM, Kelly C, Ramjee G, et al. Association between hormonal contraception and HIV infection in HPTN 035 [presentation]. International Microbicides Conference; April, 2012; Sydney.
- Naicker I, Crook AM, Ramjee G. Hormonal contraception and the risk of HIV and sexually transmitted infection acquisition – lessons from the MDP Feasibility Study. International Microbicides Conference; April, 2012; Sydney.
- M Rodriguez, M Reeves, A Caughey. Evaluating the competing risks of HIV acquisition and maternal mortality in Africa: a decision analysis. BJOG: An International Journal of Obstetrics and Gynaecology. 119(9): 2012; 1067–1073.
- World Health Organization. Medical eligibility criteria for contraceptive use. 2010; World Health Organization: Geneva.
- RH Gray, X Li, G Kigozi. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. The Lancet. 366: 2005; 1182–1188.
- NR Mugo, R Heffron, D Donnell. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples. AIDS. 25(15): 2011; 1887–1895.
- Jain AK. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies. Contraception 2012; 10.1016/j.contraception.2012.03.008.